 | Up a level |
2022
Kroese, Tiuri E. 
ORCID: 0000-0002-5569-4164, van Hillegersberg, Richard, Schoppmann, Sebastian, Deseyne, Pieter R. A. J., Nafteux, Philippe, Obermannova, Radka, Nordsmark, Marianne, Pfeiffer, Per ORCID: 0000-0002-2925-0586, Hawkins, Maria A., Smyth, Elizabeth, Markar, Sheraz, Hanna, George B., Cheong, Edward, Chaudry, Asif, Elme, Anneli, Adenis, Antoine, Piessen, Guillaume, Gani, Cihan, Bruns, Christiane J., Moehler, Markus, Liakakos, Theodore, Reynolds, John, Morganti, Alessio, Rosati, Riccardo, Castoro, Carlo ORCID: 0000-0001-9601-9336, D'Ugo, Domenico, Roviello, Franco, Bencivenga, Maria, de Manzoni, Giovanni, Jeene, Paul, van Sandick, Johanna W., Muijs, Christel, Slingerland, Marije, Nieuwenhuijzen, Grard, Wijnhoven, Bas, Beerepoot, Laurens, V, Kolodziejczyk, Piotr, Polkowski, Wojciech P., Alsina, Maria, Pera, Manuel, Kanonnikoff, Tania F., Nilsson, Magnus, Guckenberger, Matthias ORCID: 0000-0002-7146-9071, Monig, Stefan, Wagner, Dorethea, Wyrwicz, Lucjan, Berbee, Maaike, Gockel, Ines, Lordick, Florian, Griffiths, Ewen A., Verheij, Marcel, van Rossum, Peter S. N. and van Laarhoven, Hanneke W. M.
(2022).
Definitions and treatment of oligometastatic oesophagogastric cancer according to multidisciplinary tumour boards in Europe.
Eur. J. Cancer, 164.
S. 18 - 30.
OXFORD:
ELSEVIER SCI LTD.
ISSN 1879-0852
Shitara, Kohei, Ajani, Jaffer A., Moehler, Markus, Garrido, Marcelo, Gallardo, Carlos, Shen, Lin, Yamaguchi, Kensei, Wyrwicz, Lucjan, Skoczylas, Tomasz ORCID: 0000-0002-1276-3828, Bragagnoli, Arinilda Campos, Liu, Tianshu, Tehfe, Mustapha, Elimova, Elena, Bruges, Ricardo, Zander, Thomas, de Azevedo, Sergio, Kowalyszyn, Ruben, Pazo-Cid, Roberto, Schenker, Michael ORCID: 0000-0003-2645-6391, Cleary, James M., Yanez, Patricio, Feeney, Kynan, Karamouzis, Michalis, V, Poulart, Valerie, Lei, Ming, Xiao, Hong, Kondo, Kaoru, Li, Mingshun and Janjigian, Yelena Y.
(2022).
Nivolumab plus chemotherapy or ipilimumab in gastro-oesophageal cancer.
Nature, 603 (7903).
S. 942 - 963.
BERLIN:
NATURE PORTFOLIO.
ISSN 1476-4687
2021
Janjigian, Yelena Y., Shitara, Kohei, Moehler, Markus, Garrido, Marcelo, Salman, Pamela, Shen, Lin, Wyrwicz, Lucjan ORCID: 0000-0003-0808-6892, Yamaguchi, Kensei, Skoczylas, Tomasz ORCID: 0000-0002-1276-3828, Bragagnoli, Arinilda Campos, Liu, Tianshu, Schenker, Michael ORCID: 0000-0003-2645-6391, Yanez, Patricio, Tehfe, Mustapha, Kowalyszyn, Ruben, Karamouzis, Michalis V., Bruges, Ricardo, Zander, Thomas, Pazo-Cid, Roberto, Hitre, Erika, Feeney, Kynan, Cleary, James M., Poulart, Valerie, Cullen, Dana, Lei, Ming, Xiao, Hong, Kondo, Kaoru, Li, Mingshun and Ajani, Jaffer A.
(2021).
First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial.
Lancet, 398 (10294).
S. 27 - 41.
NEW YORK:
ELSEVIER SCIENCE INC.
ISSN 1474-547X